The MarketReader Minute
💊 Regeneron Tumbles Amid Court Ruling, While BioNTech Gains on Vaccine News and IDEAYA Faces Pressure Despite Positive Data | Biotech Sector Insights
Regeneron Pharmaceuticals Inc. (REGN) saw a notable drop, attributed to a federal court ruling that denied its request for a preliminary injunction against Amgen's biosimilar of Eylea, leading to a substantial decline over the past month and subsequent analyst downgrades